HHS considering action on drug patents over high prices

10 February 2016 - US Health and Human Services Secretary Sylvia Burwell said Wednesday that her department is considering issuing guidelines on an executive action known as “march-in rights” as a way to fight high drug prices.

For more details, go to: http://thehill.com/policy/healthcare/269003-hhs-considering-action-on-drug-patents-over-high-prices?utm_medium=nl&utm_source=internal&mkt_tok=3RkMMJWWfF9wsRokuq3Bcu%2FhmjTEU5z17%2BkqUKG3iokz2EFye%2BLIHETpodcMSMdiMr%2FYDBceEJhqyQJxPr3HJdQN18R7RhHnDg%3D%3D

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing